Salvia divinorum: Toxicological aspects and analysis in human biological specimens

Bioanalysis

Volume 8, Issue 13, July 2016, Pages 1415-1425

  (Review)

Margalho, C.^a, 

Corte-Real, F.^ab, 

López-Rivadulla, M.^c, 

Gallardo, E.^de 

 

^a  Instituto Nacional de Medicina Legal e Ciências Forenses, I.P. (INMLCF, I.P.) - Delegação do Centro, Coimbra, Portugal
^b  Faculdade de Medicina, Universidade de Coimbra, Coimbra, 

View additional affiliations

View references (80)

Abstract

The identification and quantitation of the main psychoactive component of Salvia divinorum (salvinorin A) in biological specimens are crucial in forensic and clinical toxicology. Despite all the efforts made, its uncontrolled abuse has increased quickly, exposing its users' health to serious risks both in the short and long term. The use of alternative biological matrices in toxicological analyzes can be advantageous as complementary postmortem samples, or in situations when neither blood nor urine can be collected; they may be useful tools in those determinations, providing important information about prior exposure. The aim of this article is to present a brief summary of legal aspects of Salvia divinorum and salvinorin A, including the methods used for the determination of the latter in biological matrices. © 2016 Future Science Ltd.

Author keywords

analytical methodologies; Salvia divinorum; salvinorin A

ISSN: 17576180Source Type: Journal Original language: English

DOI: 10.4155/bio-2016-0067Document Type: Review

Publisher: Future Science Ltd

References (80)

View in search results format

• All
 
• • Export |
  • Print |
  • E-mail |
  • Create bibliography

• 
  1

  (2015) European Drug Report 2015: Trends and Developments. Cited 19 times.
  European Monitoring Centre for Drugs and Drug Addiction (EMCDDA
  www.emcdda.europa.eu/publications/edr
  

  •  
• 
  2

  (2015) New Psychoactive Substances in Europe EU Early Warning System
  EMCDDA
  www.emcdda.europa.eu
  

  •  
• 
  3

  (2006) European Monitoring Centre for Drugs and Drug Addiction Annual Report
  EMCDDA
  www.emcdda.europa.eu/publications/annual-report/2006
  

  •  
• 
  4

  Vohra, R., Seefeld, A., Cantrell, F.L., Clark, R.F.

  Salvia divinorum: Exposures reported to a statewide poison control system over 10 years
  (2011) Journal of Emergency Medicine, 40 (6), pp. 643-650. Cited 25 times.
  doi: 10.1016/j.jemermed.2009.05.019
  

  • View at Publisher
• 
  5

  Appel, J., Kim-Appel, D.

  The rise of a new psychoactive agent: Salvia divinorum
  (2007) International Journal of Mental Health and Addiction, 5 (3), pp. 248-253. Cited 8 times.
  doi: 10.1007/s11469-007-9086-4
  

  • View at Publisher
• 
  6

  Mahendran, R., Lim, H.A., Tan, J.Y.S., Chua, S.M., Winslow, M.

  Salvia divinorum: An overview of the usage, misuse, and addiction processes
  (2016) Asia-Pacific Psychiatry, 8 (1), pp. 23-31.
  http://www.interscience.wiley.com/jpages/1758-5864
  doi: 10.1111/appy.12225
  

  • View at Publisher
• 
  7

  European Monitoring Centre for Drugs and Drug Addiction Annual Report 2008 the State of the Drugs Problem in Europe
  EMCDDA
  www.emcdda.europa.eu/publications/annual-report/2008
  

  •  
• 
  8

  Winstock, A., Wilkins, C.
  (2011) Legal Highs: The Challenge of New Psychoactive Substances. Cited 5 times.
  www.tni.org/files/download/dlr16.pdf
  

  •  
• 
  9

  Rech, M.A., Donahey, E., Cappiello Dziedzic, J.M., Oh, L., Greenhalgh, E.

  New drugs of abuse
  (2015) Pharmacotherapy, 35 (2), pp. 189-197. Cited 7 times.
  http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1875-9114/issues
  doi: 10.1002/phar.1522
  

  • View at Publisher
• 
  10

  Siebert, D.
  (2015) The Salvia Divinorum Research and Information Center
  www.sagewisdom.org/danielsiebert.html
  

  •  
• 
  11

  Rosenbaum, C.D., Carreiro, S.P., Babu, K.M.

  Here Today, Gone Tomorrow. and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines
  (2012) Journal of Medical Toxicology, 8 (1), pp. 15-32. Cited 140 times.
  doi: 10.1007/s13181-011-0202-2
  

  • View at Publisher
• 
  12

  Valdés, L.J.

  Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A
  (1994) Journal of Psychoactive Drugs, 26 (3), pp. 277-283. Cited 106 times.
  doi: 10.1080/02791072.1994.10472441
  

  • View at Publisher
• 
  13

  (2011) Salvia Divinorum. Cited 2 times.
  EMCDDA EMCDDA Lisbon
  www.emcdda.europa.eu/publications/drug-profiles/salvia
  

  •  
• 
  14

  González, D., Riba, J., Bouso, J.C., Gómez-Jarabo, G., Barbanoj, M.J.

  Pattern of use and subjective effects of Salvia divinorum among recreational users
  (2006) Drug and Alcohol Dependence, 85 (2), pp. 157-162. Cited 93 times.
  doi: 10.1016/j.drugalcdep.2006.04.001
  

  • View at Publisher
• 
  15

  Barnes, B.B., Snow, N.H.

  Analysis of Salvinorin A in plants, water, and urine using solid-phase microextraction-comprehensive two-dimensional gas chromatography-time of flight mass spectrometry
  (2012) Journal of Chromatography A, 1226, pp. 110-115. Cited 11 times.
  doi: 10.1016/j.chroma.2011.09.056
  

  • View at Publisher
• 
  16

  Butelman, E.R., Harris, T.J., Kreek, M.J.

  The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys
  (2004) Psychopharmacology, 172 (2), pp. 220-224. Cited 79 times.
  doi: 10.1007/s00213-003-1638-0
  

  • View at Publisher
• 
  17

  Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J.K., Siebert, D.J., Toth, B.A., (...), Roth, B.L.

  Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations
  (2004) Journal of Pharmacology and Experimental Therapeutics, 308 (3), pp. 1197-1203. Cited 137 times.
  doi: 10.1124/jpet.103.059394
  

  • View at Publisher
• 
  18

  Díaz, J.

  Salvia divinorum: A psychopharmacological riddle and a mind-body prospect
  (2013) Current Drug Abuse Reviews, 6 (1), pp. 43-53. Cited 7 times.
  doi: 10.2174/18744737112059990004
  

  • View at Publisher
• 
  19

  Giroud, C., Felber, F., Augsburger, M., Horisberger, B., Rivier, L., Mangin, P.

  Salvia divinorum: An hallucinogenic mint which might become a new recreational drug in Switzerland
  (2000) Forensic Science International, 112 (2-3), pp. 143-150. Cited 52 times.
  doi: 10.1016/S0379-0738(00)00180-8
  

  • View at Publisher
• 
  20

  Grundmann, O., Phipps, S.M., Zadezensky, I., Butterweck, V.

  Salvia divinorum and salvinorin A: An update on pharmacology and analytical methodology
  (2007) Planta Medica, 73 (10), pp. 1039-1046. Cited 36 times.
  doi: 10.1055/s-2007-981566
  

  • View at Publisher
• 
  21

  Johnson, M.W., MacLean, K.A., Reissig, C.J., Prisinzano, T.E., Griffiths, R.R.

  Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
  (2011) Drug and Alcohol Dependence, 115 (1-2), pp. 150-155. Cited 55 times.
  doi: 10.1016/j.drugalcdep.2010.11.005
  

  • View at Publisher
• 
  22

  Listos, J., Merska, A., Fidecka, S.

  Pharmacological activity of Salvinorin A, the major component of Salvia divinorum
  (2011) Pharmacological Reports, 63 (6), pp. 1305-1309. Cited 12 times.
  http://www.if-pan.krakow.pl/pjp/pdf/2011/6_1305.pdf
  

  • View at Publisher
• 
  23

  MacLean, K.A., Johnson, M.W., Reissig, C.J., Prisinzano, T.E., Griffiths, R.R.

  Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects
  (2013) Psychopharmacology, 226 (2), pp. 381-392. Cited 27 times.
  doi: 10.1007/s00213-012-2912-9
  

  • View at Publisher
• 
  24

  Margalho, C., Gallardo, E., Castanheira, A., Vieira, D.N., López-Rivadulla, M., Real, F.C.

  A validated procedure for detection and quantitation of salvinorin a in pericardial fluid, vitreous humor, whole blood and plasma using solid phase extraction and gas chromatography-mass spectrometry
  (2013) Journal of Chromatography A, 1304, pp. 203-210. Cited 6 times.
  doi: 10.1016/j.chroma.2013.07.031
  

  • View at Publisher
• 
  25

  Moreno, I., Da Fonseca, B., Oppolzer, D., Martinho, A., Barroso, M., Cruz, A., Queiroz, J.A., (...), Gallardo, E.

  Analysis of Salvinorin A in urine using microextraction in packed syringe and GC-MS/MS
  (2013) Bioanalysis, 5 (6), pp. 661-668. Cited 9 times.
  doi: 10.4155/bio.13.18
  

  • View at Publisher
• 
  26

  Pichini, S., Marchei, E., García-Algar, O., Gomez, A., Di Giovannandrea, R., Pacifici, R.

  Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers
  (2014) Journal of Pharmaceutical and Biomedical Analysis, 100, pp. 284-289. Cited 3 times.
  www.elsevier.com/locate/jpba
  doi: 10.1016/j.jpba.2014.08.006
  

  • View at Publisher
• 
  27

  Stogner, J., Khey, D.N., Griffin, O.H., Miller, B.L., Boman, J.H.

  Regulating a novel drug: An evaluation of changes in use of Salvia divinorum in the first year of Florida's ban
  (2012) International Journal of Drug Policy, 23 (6), pp. 512-521. Cited 13 times.
  doi: 10.1016/j.drugpo.2012.03.001
  

  • View at Publisher
• 
  28

  Tidgewell, K., Harding, W.W., Schmidt, M., Holden, K.G., Murry, D.J., E. Prisinzano, T.

  A facile method for the preparation of deuterium labeled salvinorin A: Synthesis of [2,2,2- 2H 3]-salvinorin a
  (2004) Bioorganic and Medicinal Chemistry Letters, 14 (20), pp. 5099-5102. Cited 41 times.
  doi: 10.1016/j.bmcl.2004.07.081
  

  • View at Publisher
• 
  29

  Cunningham, C.W., Rothman, R.B., Prisinzano, T.E.

  Neuropharmacology of the naturally occurring κ-opioid hallucinogen salvinorin A
  (2011) Pharmacological Reviews, 63 (2), pp. 316-347. Cited 46 times.
  http://pharmrev.aspetjournals.org/content/63/2/316.full.pdf+html
  doi: 10.1124/pr.110.003244
  

  • View at Publisher
• 
  30

  (2012) Europol New Drugs in Europe 2012 (EMCDDA-Europol
  EMCDDA. Annual Report on the implementation of Council Decision 2005/387/JHA7/JHA Luxembourg. Publications Office of the European Union, Luxembourg
  

  •  
• 
  31

  Gibbons, S., Arunotayanun, W.
  (2013) Natural Product (Fungal and Herbal), Novel Psychoactive Substances, pp. 345-362.
  Novel Psychoactive Substances, Classification, Pharmacology and Toxicology. Academic Press, London, UK
  

  •  
• 
  32

  ValdÉs, L.J., Hatheld, G.M., Koreeda, M., Paul, A.G.

  Studies of Salvia divinorum (Lamiaceae), an Hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico
  (1987) Economic Botany, 41 (2), pp. 283-291. Cited 28 times.
  doi: 10.1007/BF02858975
  

  • View at Publisher
• 
  33

  Butelman, E.R., Kreek, M.J.

  Salvinorin A, a kappa-opioid receptor agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
  (2015) Frontiers in Pharmacology, 6 (SEP), art. no. 190. Cited 3 times.
  http://journal.frontiersin.org/article/10.3389/fphar.2015.00190/full
  doi: 10.3389/fphar.2015.00190
  

  • View at Publisher
• 
  34

  Bücheler, R., Gleiter, C.H., Schwoerer, P., Gaertner, I.

  Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage)
  (2005) Pharmacopsychiatry, 38 (1), pp. 1-5. Cited 43 times.
  doi: 10.1055/s-2005-837763
  

  • View at Publisher
• 
  35

  Zawilska, J.B., Wojcieszak, J.

  Salvia divinorum: From Mazatec medicinal and hallucinogenic plant to emerging recreational drug
  (2013) Human Psychopharmacology, 28 (5), pp. 403-412. Cited 13 times.
  doi: 10.1002/hup.2304
  

  • View at Publisher
• 
  36

  Deluca, P.
  (2009) Psychonaut Web Mapping Research Group 2009
  Salvia Divinorum Report Psychiatry, King's Coll. London, UK
  www.psychonautproject.eu/documents/reports/Salvia.pdf
  

  •  
• 
  37

  Salvia Divinorum Establish Restrictions but Don't Criminalize It, pp. 25-34.
  Drug Policy Alliance
  www.drugpolicy.org/sites/default/files/FactSheet-Salvia.pdf
  

  •  
• 
  38

  Salvia Divinorum Defense Fund
  Center for Cognitive Liberty, & Ethics
  www.cognitiveliberty.org
  

  •  
• 
  39

  Siebert, D.J.

  Salvia divinorum and salvinorin A: new pharmacologic findings
  (1994) Journal of Ethnopharmacology, 43 (1), pp. 53-56. Cited 196 times.
  doi: 10.1016/0378-8741(94)90116-3
  

  • View at Publisher
• 
  40

  Cardellino, C.
  (2013) Salvia Divinorum Drugs
  http://flipper.diff.org/app/items/5403
  

  •  
• 
  41

  Mendelson, J.E., Coyle, J.R., Lopez, J.C., Baggott, M.J., Flower, K., Everhart, E.T., Munro, T.A., (...), Cohen, B.M.

  Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: A placebo-controlled trial
  (2011) Psychopharmacology, 214 (4), pp. 933-939. Cited 17 times.
  doi: 10.1007/s00213-010-2103-5
  

  • View at Publisher
• 
  42

  Meyer, E.G., Writer, B.W.

  Salvia divinorum.
  (2012) Psychosomatics, 53 (3), pp. 277-279. Cited 7 times.
  

  • View at Publisher
• 
  43

  Teksin, Z.S., Lee, I.J., Nemieboka, N.N., Othman, A.A., Upreti, V.V., Hassan, H.E., Syed, S.S., (...), Eddington, N.D.

  Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
  (2009) European Journal of Pharmaceutics and Biopharmaceutics, 72 (2), pp. 471-477. Cited 27 times.
  doi: 10.1016/j.ejpb.2009.01.002
  

  • View at Publisher
• 
  44

  Valdes III, L.J., Butler, W.M., Hatfield, G.M., Paul, A.G., Koreeda, M.

  Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint Salvia divinorum
  (1984) Journal of Organic Chemistry, 49 (24), pp. 4716-4720. Cited 125 times.
  

  • View at Publisher
• 
  45

  Imanshahidi, M., Hosseinzadeh, H.

  The pharmacological effects of Salvia species on the central nervous system
  (2006) Phytotherapy Research, 20 (6), pp. 427-437. Cited 92 times.
  doi: 10.1002/ptr.1898
  

  • View at Publisher
• 
  46

  Siebert, D.J.

  Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum
  (2004) Annals of Botany, 93 (6), pp. 763-771. Cited 57 times.
  doi: 10.1093/aob/mch089
  

  • View at Publisher
• 
  47

  Kutrzeba, L.M., Li, X.-C., Ding, Y., Ferreira, D., Zjawiony, J.K.

  Intramolecular transacetylation in salvinorins D and E
  (2010) Journal of Natural Products, 73 (4), pp. 707-708. Cited 6 times.
  doi: 10.1021/np900447w
  

  • View at Publisher
• 
  48

  Lee, D.Y.W., Ma, Z., Liu-Chen, L.-Y., Wang, Y., Chen, Y., Carlezon Jr., W.A., Cohen, B.

  New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human κ opioid receptors
  (2005) Bioorganic and Medicinal Chemistry, 13 (19), pp. 5635-5639. Cited 47 times.
  doi: 10.1016/j.bmc.2005.05.054
  

  • View at Publisher
• 
  49

  Munro, T.A., Rizzacasa, M.A.

  Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A
  (2003) Journal of Natural Products, 66 (5), pp. 703-705. Cited 71 times.
  doi: 10.1021/np0205699
  

  • View at Publisher
• 
  50

  Shirota, O., Nagamatsu, K., Sekita, S.

  Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum
  (2006) Journal of Natural Products, 69 (12), pp. 1782-1786. Cited 37 times.
  doi: 10.1021/np060456f
  

  • View at Publisher
• 
  51

  Valdés III, L.J., Chang, H.-M., Visger, D.C., Koreeda, M.

  Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum
  (2001) Organic Letters, 3 (24), pp. 3935-3937. Cited 60 times.
  doi: 10.1021/ol016820d
  

  • View at Publisher
• 
  52

  Bigham, A.K., Munro, T.A., Rizzacasa, M.A., Robins-Browne, R.M.

  Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum
  (2003) Journal of Natural Products, 66 (9), pp. 1242-1244. Cited 52 times.
  

  • View at Publisher
• 
  53

  Prisinzano, T.E.

  Psychopharmacology of the hallucinogenic sage Salvia divinorum
  (2005) Life Sciences, 78 (5), pp. 527-531. Cited 68 times.
  doi: 10.1016/j.lfs.2005.09.008
  

  • View at Publisher
• 
  54

  Schmidt, M.S., Prisinzano, T.E., Tidgewell, K., Harding, W., Butelman, E.R., Kreek, M.J., Murry, D.J.

  Determination of Salvinorin A in body fluids by high performance liquid chromatography-atmospheric pressure chemical ionization
  (2005) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 818 (2), pp. 221-225. Cited 40 times.
  doi: 10.1016/j.jchromb.2004.12.041
  

  • View at Publisher
• 
  55

  Pichini, S., Abanades, S., Farré, M., Pellegrini, M., Marchei, E., Pacifici, R., De La Torre, R., (...), Zuccaro, P.

  Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking
  (2005) Rapid Communications in Mass Spectrometry, 19 (12), pp. 1649-1656. Cited 38 times.
  doi: 10.1002/rcm.1970
  

  • View at Publisher
• 
  56

  McDonough, P.C., Holler, J.M., Vorec, S.P., Bosy, T.Z., Magluilo Jr., J., Past, M.R.

  The detection and quantitative analysis of the psychoactive component of Salvia divinorum, salvinorin a, in human biological fluids using liquid chromatography-mass spectrometry
  (2008) Journal of Analytical Toxicology, 32 (6), pp. 417-421. Cited 13 times.
  http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/45243306.1/pres/jat/2008/00000032/00000006/art00004/194439257BD2E96812169518788AE9B4CDD91253F3.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
  

  • View at Publisher
• 
  57

  Johnson, M.W., MacLean, K.A., Reissig, C.J., Prisinzano, T.E., Griffiths, R.R.

  Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
  (2011) Drug and Alcohol Dependence, 115 (1-2), pp. 150-155. Cited 55 times.
  doi: 10.1016/j.drugalcdep.2010.11.005
  

  • View at Publisher
• 
  58

  Hooker, J.M., Munro, T.A., Béguin, C., Alexoff, D., Shea, C., Xu, Y., Cohen, B.M.

  Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence
  (2009) Neuropharmacology, 57 (4), pp. 386-391. Cited 17 times.
  doi: 10.1016/j.neuropharm.2009.06.044
  

  • View at Publisher
• 
  59

  Roth, B.L., Baner, K., Westkaemper, R., Siebert, D., Rice, K.C., Steinberg, S., Ernsberger, P., (...), Rothman, R.B.

  Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
  (2002) Proceedings of the National Academy of Sciences of the United States of America, 99 (18), pp. 11934-11939. Cited 434 times.
  doi: 10.1073/pnas.182234399
  

  • View at Publisher
• 
  60

  Namera, A., Kawamura, M., Nakamoto, A., Saito, T., Nagao, M.

  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones
  (2015) Forensic Toxicology, 33 (2), pp. 175-194. Cited 10 times.
  http://www.springerlink.com/content/1860-8965
  doi: 10.1007/s11419-015-0270-0
  

  • View at Publisher
• 
  61

  Saito, K., Saito, R., Kikuchi, Y., Iwasaki, Y., Ito, R., Nakazawa, H.

  Analysis of drugs of abuse in biological specimens
  (2011) Journal of Health Science, 57 (6), pp. 472-487. Cited 11 times.
  http://www.jstage.jst.go.jp/article/jhs/57/6/472/_pdf
  
• 
  62

  Gallardo, E., Queiroz, J.A.

  The role of alternative specimens in toxicological analysis
  (2008) Biomedical Chromatography, 22 (8), pp. 795-821. Cited 78 times.
  doi: 10.1002/bmc.1009
  

  • View at Publisher
• 
  63

  Bévalot, F., Cartiser, N., Bottinelli, C., Fanton, L., Guitton, J.

  Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review
  (2016) Forensic Toxicology, 34 (1), pp. 12-40.
  http://www.springerlink.com/content/1860-8965
  doi: 10.1007/s11419-015-0294-5
  

  • View at Publisher
• 
  64

  Kerrigan, S.
  Sampling, storage and stability
  (2013) Clarke's Analytical Forensic Toxicology. Cited 4 times.
  2nd Edition Pharmaceutical Press London, UK
  

  •  
• 
  65

  Drummer, O.H.

  Requirements for bioanalytical procedures in postmortem toxicology
  (2007) Analytical and Bioanalytical Chemistry, 388 (7), pp. 1495-1503. Cited 53 times.
  doi: 10.1007/s00216-007-1238-7
  

  • View at Publisher
• 
  66

  Pounder, D.J., Fuke, C., Cox, D.E., Smith, D., Kuroda, N.

  Postmortem diffusion of drugs from gastric residue: An experimental study
  (1996) American Journal of Forensic Medicine and Pathology, 17 (1), pp. 1-7. Cited 59 times.
  doi: 10.1097/00000433-199603000-00001
  

  • View at Publisher
• 
  67

  Pélissier-Alicot, A.-L., Gaulier, J.-M., Champsaur, P., Marquet, P.

  Mechanisms Underlying Postmortem Redistribution of Drugs: A Review
  (2003) Journal of Analytical Toxicology, 27 (8), pp. 533-544. Cited 109 times.
  

  • View at Publisher
• 
  68

  Drummer, O.H.

  Postmortem toxicology of drugs of abuse
  (2004) Forensic Science International, 142 (2-3), pp. 101-113. Cited 130 times.
  doi: 10.1016/j.forsciint.2004.02.013
  

  • View at Publisher
• 
  69

  Jermain, J.D., Evans, H.K.

  Analyzing salvia divinorum and its active ingredient salvinorin a utilizing thin layer chromatography and gas chromatography/mass spectrometry
  (2009) Journal of Forensic Sciences, 54 (3), pp. 612-616. Cited 16 times.
  doi: 10.1111/j.1556-4029.2009.00999.x
  

  • View at Publisher
• 
  70

  Moriya, F., Hashimoto, Y.

  Pericardial fluid as an alternative specimen to blood for postmortem toxicological analyses
  (1999) Legal Medicine, 1 (2), pp. 86-94. Cited 24 times.
  doi: 10.1016/S1344-6223(99)80018-2
  

  • View at Publisher
• 
  71

  Moriya, F., Hashimoto, Y.

  Criteria for judging whether postmortem blood drug concentrations can be used for toxicologic evaluation
  (2000) Legal Medicine, 2 (3), pp. 143-151. Cited 16 times.
  doi: 10.1016/S1344-6223(00)80014-0
  

  • View at Publisher
• 
  72

  Laloup, M., De Boeck, G.N.S.
  Unconventional samples and alternative matrices
  (2008) Handbook of Analytical Separations
  Elsevier Amsterdam The Netherlands
  

  •  
• 
  73

  Queiroz, J.A., Gallardo, E., Barroso, M.

  What are the recent advances in forensic oral fluid bioanalysis?
  (2013) Bioanalysis, 5 (17), pp. 2077-2079. Cited 2 times.
  doi: 10.4155/bio.13.186
  

  • View at Publisher
• 
  74

  Barroso, M., Gallardo, E.

  Sampling alternative specimens: Hair and oral fluid
  (2015) New Sampling Strategies in Toxicology and Therapeutic Drug Monitoring, pp. 111-118.
  http://www.futuremedicine.com/doi/book/10.4155/9781910420072
  ISBN: 978-191042007-2; 978-191042009-6
  doi: 10.4155/fseb2013.14.88
  

  • View at Publisher
• 
  75

  Jenkins, A.J.
  (2008) Drug Testing in Alternate Biological Specimens. Cited 9 times.
  Humana Press NY USA
  

  •  
• 
  76

  Cooper, G.A.A., Kronstrand, R., Kintz, P.

  Society of Hair Testing guidelines for drug testing in hair
  (2012) Forensic Science International, 218 (1-3), pp. 20-24. Cited 132 times.
  doi: 10.1016/j.forsciint.2011.10.024
  

  • View at Publisher
• 
  77

  Barroso, M., Gallardo, E., Vieira, D.N., López-Rivadulla, M., Queiroz, J.A.

  Hair: A complementary source of bioanalytical information in forensic toxicology
  (2011) Bioanalysis, 3 (1), pp. 67-79. Cited 24 times.
  doi: 10.4155/bio.10.171
  

  • View at Publisher
• 
  78

  Prisinzano, T.E.

  Neoclerodanes as atypical opioid receptor ligands^†
  (2013) Journal of Medicinal Chemistry, 56 (9), pp. 3435-3443. Cited 13 times.
  doi: 10.1021/jm400388u
  

  • View at Publisher
• 
  79

  Roth, B.L., Lopez, E., Beischel, S., Westkaemper, R.B., Evans, J.M.

  Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: A novel approach for CNS drug discovery
  (2004) Pharmacology and Therapeutics, 102 (2), pp. 99-110. Cited 75 times.
  doi: 10.1016/j.pharmthera.2004.03.004
  

  • View at Publisher
• 
  80

  Sheffler, D.J., Roth, B.L.

  Salvinorin A: The 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor
  (2003) Trends in Pharmacological Sciences, 24 (3), pp. 107-109. Cited 102 times.
  doi: 10.1016/S0165-6147(03)00027-0
  

  • View at Publisher

  Gallardo, E.; Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, Portugal; email:egallardo@fcsaude.ubi.pt
© Copyright 2016 Elsevier B.V., All rights reserved.